Latigo Biotherapeutics, Inc. (LTGO) Executive Compensation
Latigo Biotherapeutics, Inc. (LTGO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LTGO
CIK: 2056611
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerOusmane Caba
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-09-03 | 2026-06-30 | 10-Q | 0001193125-26-381969 | View SEC Doc Filr Page |
| 8-K | 2026-09-03 | 2026-09-03 | 8-K | 0001193125-26-381912 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-18 | — | SCHEDULE 13G Filing | 0001193125-26-355798 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-17 | — | SCHEDULE 13D Filing | 0001104659-26-097980 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-17 | — | SCHEDULE 13G Filing | 0001346824-26-000233 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0001172661-26-003404 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | 4 Filing | 0001231919-26-000869 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | 4 | 0001193125-26-345826 | View SEC Doc Filr Page |
| 3 | 2026-08-12 | 2026-08-06 | 3 | 0001193125-26-345811 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-10 | OWNERSHIP DOCUMENT | 0001104659-26-093633 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-10 | OWNERSHIP DOCUMENT | 0001104659-26-093580 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 Filing | 0001523672-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-10 | 4 Filing | 0001581754-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-10 | 4 Filing | 0001184592-26-000005 | View SEC Doc Filr Page |
| S-8 | 2026-08-10 | — | S-8 | 0001193125-26-342582 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-342321 | View SEC Doc Filr Page |
| 424B4 | 2026-08-07 | — | 424B4 | 0001193125-26-340329 | View SEC Doc Filr Page |
| EFFECT | 2026-08-06 | — | EFFECT Filing | 9999999995-26-002566 | View SEC Doc Filr Page |
| 3 | 2026-08-06 | 2026-08-06 | OWNERSHIP DOCUMENT | 0001104659-26-092247 | View SEC Doc Filr Page |
| 3 | 2026-08-06 | 2026-08-06 | 3 Filing | 0001231919-26-000841 | View SEC Doc Filr Page |
| 3 | 2026-08-06 | 2026-08-06 | OWNERSHIP DOCUMENT | 0001104659-26-092240 | View SEC Doc Filr Page |
| 3 | 2026-08-06 | 2026-08-06 | 3 Filing | 0002144246-26-000002 | View SEC Doc Filr Page |
| 3 | 2026-08-06 | 2026-08-06 | 3 Filing | 0001349376-26-000006 | View SEC Doc Filr Page |
| 3 | 2026-08-06 | 2026-08-06 | 3 Filing | 0001866171-26-000002 | View SEC Doc Filr Page |
| 3 | 2026-08-06 | 2026-08-06 | 3 Filing | 0001523672-26-000006 | View SEC Doc Filr Page |